Mechanism of epinephrine and serotonin inhibition of insulin release in the golden hamster in vitro.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D006224:Cricetinae; D000242:Cyclic AMP / Q000037:antagonists & inhibitors; D003864:Depression, Chemical; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005947:Glucose / Q000037:antagonists & inhibitors; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008298:Maleates / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011863:Radioimmunoassay; D012701:Serotonin / Q000494:pharmacology*; D012702:Serotonin Antagonists
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D007328:Insulin; D008298:Maleates; D012702:Serotonin Antagonists; D012701:Serotonin; D011433:Propranolol; D000242:Cyclic AMP; D005947:Glucose; D008784:Methysergide; D004837:Epinephrine; D010646:Phentolamine